SMN2 and proximal spinal muscular atrophy: Together, our findings underline the potential benefits of using untargeted 1H-NMR spectroscopy-based metabolic profiling as an additional tool complementing current stratification strategies, such as SMN2 copy numbers and CMAP-testing, in predicting the severity of patients with SMA.